Mankind Pharma Ltd
MANKINDMankind Pharma Ltd
MANKINDPrice Chart
How to use scorecard? Learn more
Key Metrics
No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
---|---|---|
50.51 | 11.16 | — |
Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
---|---|---|
51.53 | 6.56 | 0.52% |
Forecast & Ratings
Detailed Forecast from 15 analysts
Price
Price Upside
Earnings
Earnings Growth
Revenue
Rev. Growth
Company Profile
Mankind Pharma Ltd develops and markets a wide range of pharmaceutical formulations across various therapeutic areas, including anti-infectives and cardiovascular products.
Investor Presentation
View olderPeers
Compare with peersSun Pharmaceutical Industries Ltd
Cipla Ltd
Torrent Pharmaceuticals Ltd
Dr Reddy's Laboratories Ltd
Zydus Lifesciences Ltd
Get more out of Tickertape, Go Pro!
Customise key metrics, see detailed forecasts, download stock data and more
Forecasts
Price
Revenue
Earnings
Price Forecast
All values in ₹
All values in ₹
Revenue Forecast
All values in ₹ Thousand cr.
All values in ₹ Thousand cr.
Earnings Per Share Forecast
All values in ₹
All values in ₹
Income
Balance Sheet
Cash Flow
Income Statement
Financial Year | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | TTM | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Total Revenue | 5,987.19 | 6,397.06 | 7,992.04 | 8,890.42 | 10,630.84 | 11,403.77 | ||||||
Raw Materials | 1,888.53 | 2,028.00 | 2,871.32 | 2,622.90 | 3,263.37 | 8,288.58 | ||||||
Power & Fuel Cost | 79.96 | 82.53 | 103.13 | 108.96 | 129.30 | |||||||
Employee Cost | 1,335.53 | 1,415.78 | 1,620.59 | 1,918.47 | 2,274.73 | |||||||
Selling & Administrative Expenses | 885.85 | 1,086.44 | 1,410.01 | 1,616.92 | 1,880.42 | |||||||
Operating & Other expenses | 237.29 | -47.44 | -214.04 | 580.25 | 250.37 | |||||||
EBITDA | 1,560.03 | 1,831.75 | 2,201.03 | 2,042.92 | 2,832.65 | 3,115.19 | ||||||
Depreciation/Amortization | 99.06 | 118.97 | 166.62 | 325.92 | 398.25 | 427.78 | ||||||
PBIT | 1,460.97 | 1,712.78 | 2,034.41 | 1,717.00 | 2,434.40 | 2,687.41 | ||||||
Interest & Other Items | 23.24 | 21.16 | 59.80 | 45.76 | 35.05 | 36.58 | ||||||
PBT | 1,437.73 | 1,691.62 | 1,974.61 | 1,671.24 | 2,399.35 | 2,650.83 | ||||||
Taxes & Other Items | 407.31 | 426.19 | 541.12 | 389.39 | 486.46 | 535.87 | ||||||
Net Income | 1,030.42 | 1,265.43 | 1,433.49 | 1,281.85 | 1,912.89 | 2,114.96 | ||||||
EPS | 25.72 | 31.59 | 35.78 | 32.00 | 47.75 | 52.80 | ||||||
DPS | 0.00 | 7.60 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
Payout ratio | 0.00 | 0.24 | 0.00 | 0.00 | 0.00 | 0.00 |
Company Updates
Investor Presentation
Peers & Comparison
Health CarePharmaceuticals
Valuation
Technical
Forecast
Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
---|---|---|---|
Mankind Pharma Ltd | 55.85 | 11.16 | — |
Sun Pharmaceutical Industries Ltd | 45.35 | 6.47 | 0.75% |
Cipla Ltd | 28.51 | 4.38 | 0.89% |
Torrent Pharmaceuticals Ltd | 68.45 | 16.54 | 0.84% |
Price Comparison
Compare MANKIND with any stock or ETFShareholdings
Promoter Holdings Trend
Institutional Holdings Trend
Total Retail Holding
In last 3 months, retail holding in the company has almost stayed constant
Foreign Institutional Holding
In last 3 months, foreign institutional holding of the company has almost stayed constant
Shareholding Pattern
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Shareholding History
Mutual Funds Holding Trend
Mutual Fund Holding
In last 3 months, mutual fund holding of the company has almost stayed constant
Top 5 Mutual Funds holding Mankind Pharma Ltd
Funds (Top 5) | The rupee value of the stock held by the fund divided by the stock’s market cap Market-cap held | Percentage of the fund’s portfolio invested in the stock Weight | Change in the portfolio weight of the stock over the last 3 months 3M holding change | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months Portfolio rank(3M change) |
---|---|---|---|---|
SBI Blue Chip Fund - Growth - Direct Plan Growth | The rupee value of the stock held by the fund divided by the stock’s market cap 0.6722% | Percentage of the fund’s portfolio invested in the stock 1.42% | Change in the portfolio weight of the stock over the last 3 months 0.07% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 23/53 (+4) |
Axis ELSS Tax Saver Fund - Growth - Direct Plan Growth | The rupee value of the stock held by the fund divided by the stock’s market cap 0.2828% | Percentage of the fund’s portfolio invested in the stock 0.83% | Change in the portfolio weight of the stock over the last 3 months 0.07% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 30/92 (+1) |
SBI FUNDS MANAGEMENT PVT LTD#SBI MF-SBI CONTRA FUND DIRECT PL GROWTH Growth | The rupee value of the stock held by the fund divided by the stock’s market cap 0.2546% | Percentage of the fund’s portfolio invested in the stock 0.65% | Change in the portfolio weight of the stock over the last 3 months -0.02% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 80/111 (-2) |
Compare 3-month MF holding change on Screener
smallcases
A smallcase is a basket of stocks/ETFs that represents an idea or theme.Diversify your risk and buy smallcases that have Mankind Pharma Ltd
Events
Dividend Trend
No dividend trend available
Dividends
Corp. Actions
Announcements
Legal Orders
Dividends
Mankind Pharma Ltd gained for a third straight session today. The stock is quoting at Rs 2609.95, up 1.9% on the day as on 12:49 IST on the NSE. The benchmark NIFTY is up around 0.22% on the day, quoting at 24184. The Sensex is at 79872.83, up 0.09%. Mankind Pharma Ltd has slipped around 4.44% in last one month. Meanwhile, Nifty Pharma index of which Mankind Pharma Ltd is a constituent, has slipped around 0.69% in last one month and is currently quoting at 22240.2, up 1.08% on the day. The volume in the stock stood at 1.42 lakh shares today, compared to the daily average of 3.47 lakh shares in last one month.The PE of the stock is 51.21 based on TTM earnings ending September 24.Powered by Capital Market - Live
Mankind Pharma Ltd dropped for a fifth straight session today. The stock is quoting at Rs 2537.6, down 3.22% on the day as on 12:59 IST on the NSE. The benchmark NIFTY is down around 0.94% on the day, quoting at 23659.1. The Sensex is at 78018.99, down 0.83%.Mankind Pharma Ltd has lost around 8.04% in last one month.Meanwhile, Nifty Pharma index of which Mankind Pharma Ltd is a constituent, has eased around 7.95% in last one month and is currently quoting at 22151.6, down 1.6% on the day. The volume in the stock stood at 2.1 lakh shares today, compared to the daily average of 3.25 lakh shares in last one month.The PE of the stock is 52.54 based on TTM earnings ending September 24.Powered by Capital Market - Live
Mankind Pharma has received reaffirmation in credit ratings from CRISIL as under: Commercial paper (Rs 5,000 crore) - CRISIL A1+ Non convertible debentures (Rs 4,600 crore) - CRISIL AA+/ Stable Non convertible debentures (Rs 400 crore) - CRISIL AA+/ Stable Total bank loan facilities rated (Rs 1,250 crore) - CRISIL AA+/ Stable Powered by Capital Market - Live
Net profit of Mankind Pharma rose 30.43% to Rs 653.47 crore in the quarter ended September 2024 as against Rs 501.03 crore during the previous quarter ended September 2023. Sales rose 13.60% to Rs 3076.51 crore in the quarter ended September 2024 as against Rs 2708.10 crore during the previous quarter ended September 2023. ParticularsQuarter EndedSep. 2024Sep. 2023% Var. Sales3076.512708.10 14 OPM %27.6325.21 - PBDT954.94737.48 29 PBT849.32640.99 33 NP653.47501.03 30 Powered by Capital Market - Live
Mankind Pharma Ltd is up for a fifth straight session today. The stock is quoting at Rs 2681.1, up 0.01% on the day as on 12:44 IST on the NSE. The benchmark NIFTY is down around 1.72% on the day, quoting at 23886.05. The Sensex is at 78452.42, down 1.6%. Mankind Pharma Ltd has gained around 4.66% in last one month. Meanwhile, Nifty Pharma index of which Mankind Pharma Ltd is a constituent, has gained around 1.9% in last one month and is currently quoting at 22807.15, down 1.17% on the day. The volume in the stock stood at 2.14 lakh shares today, compared to the daily average of 2.7 lakh shares in last one month.The PE of the stock is 57.5 based on TTM earnings ending June 24.Powered by Capital Market - Live
Mankind Pharma Ltd is up for a third straight session in a row. The stock is quoting at Rs 2729.95, up 3.89% on the day as on 12:49 IST on the NSE. The benchmark NIFTY is down around 0.6% on the day, quoting at 24194.3. The Sensex is at 79405.35, down 0.67%. Mankind Pharma Ltd has risen around 5.86% in last one month. Meanwhile, Nifty Pharma index of which Mankind Pharma Ltd is a constituent, has risen around 2.54% in last one month and is currently quoting at 22374.95, up 1.48% on the day. The volume in the stock stood at 1.53 lakh shares today, compared to the daily average of 2.98 lakh shares in last one month.The PE of the stock is 56.17 based on TTM earnings ending June 24.Powered by Capital Market - Live
Mankind Pharma will hold a meeting of the Board of Directors of the Company on 5 November 2024Powered by Capital Market - Live
Mankind Pharma has received reaffirmation in credit rating for non-convertible debentures (Rs 4,600 crore) at ICRA AA+; Stable. The company has been assigned the rating ICRA A1+ and ICRA AA+; Stable for commercial papers (Rs 5,000 crore), non-convertible debentures (Rs 400 crore) and bank facilities (Rs 1,250 crore). Powered by Capital Market - Live
Mankind Pharma Ltd is up for a third straight session in a row. The stock is quoting at Rs 2631.1, up 3.76% on the day as on 12:49 IST on the NSE. The benchmark NIFTY is up around 0.3% on the day, quoting at 25867.5. The Sensex is at 84684.03, up 0.17%. Mankind Pharma Ltd has risen around 11.82% in last one month. Meanwhile, Nifty Pharma index of which Mankind Pharma Ltd is a constituent, has risen around 2.38% in last one month and is currently quoting at 23005.25, up 0.37% on the day. The volume in the stock stood at 6.1 lakh shares today, compared to the daily average of 6.37 lakh shares in last one month.The PE of the stock is 54.44 based on TTM earnings ending June 24.Powered by Capital Market - Live
The company will raise funds by way of issuance of non-convertible debentures (NCDs) and Commercial Papers (CPs) on private placement basis for an amount aggregating upto Rs 10,000 crore. The board has also constituted and authorized the Fund Raising Committee to take all necessary actions including finalization of the terms of issuance, allotment of NCDs and CPs and other related matters. Meanwhile, the company's board also approved corporate guarantees for its subsidiaries, Mankind Agritech Private, Appian Properties, Copmed Pharmaceuticals Private and Lifestar Pharma LLC. Mankind pharma is one of the largest pharmaceutical company in India, which focuses on the domestic market with its Pan India presence.Mankind pharma operates at the intersection of the Indian pharmaceutical formulations and consumer healthcare sectors with the aim of providing quality products at affordable prices. The company has 25 manufacturing facilities in India manufacturing a wide range of dosage forms, including tablets, capsules, syrups, vials, ampoules, blow fill seal, soft and hard gels, eye drops, creams, contraceptives and other over-the-counter products. The pharmaceutical company reported 10.19% increase in consolidated net profit to Rs 536.49 crore in Q1 FY25 as against Rs 486.87 crore posted in Q1 FY24.Revenue from operations stood at Rs 2,893.42 crore in Q1 FY25, up 12.20% as against with Rs 2,578.62 crore in Q1 FY24. The scrip hit all-time high at Rs 2,645 in intraday today.Powered by Capital Market - Live
Total Promoter Holding
In last 6 months, promoter holding in the company has almost stayed constant
Low Pledged Promoter Holding
Pledged promoter holdings is insignificant